Published in Nutr J on January 15, 2004
Alcohol and cardiovascular disease--modulation of vascular cell function. Nutrients (2012) 0.87
Protective effects of manganese(II) chloride on hyaluronan degradation by oxidative system ascorbate plus cupric chloride. Interdiscip Toxicol (2010) 0.79
Catabolism of hyaluronan: involvement of transition metals. Interdiscip Toxicol (2009) 0.76
Methods for nutrition monitoring in cancer patients: a cognitive perspective. Ecancermedicalscience (2012) 0.75
Wellness among African-American and Caucasian students attending a predominantly White institution. J Health Psychol (2017) 0.75
Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N Engl J Med (2003) 5.95
Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine, or spirits. BMJ (1996) 4.21
Mouse models of atherosclerosis. Science (1996) 3.49
Meta-analysis of wine and beer consumption in relation to vascular risk. Circulation (2002) 2.46
Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation. Arterioscler Thromb Vasc Biol (1997) 1.58
Toward an analogue of alcoholism in mice: scale factors in the model. Proc Natl Acad Sci U S A (1984) 1.55
The value of apolipoprotein E knockout mice for studying the effects of dietary fat and cholesterol on atherogenesis. Curr Opin Lipidol (2000) 1.06
Wine, beer and spirits and the risk of myocardial infarction: a systematic review. Biomed Pharmacother (1999) 1.01
Human apolipoprotein A-II is a pro-atherogenic molecule when it is expressed in transgenic mice at a level similar to that in humans: evidence of a potentially relevant species-specific interaction with diet. J Lipid Res (1998) 0.99
ApoA-II expression in CETP transgenic mice increases VLDL production and impairs VLDL clearance. J Lipid Res (2001) 0.97
Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia. J Lipid Res (2000) 0.89
Chronic alcohol feeding inhibits atherogenesis in C57BL/6 hyperlipidemic mice. Am J Pathol (1995) 0.87
Pitfalls of direct HDL-cholesterol measurements in mouse models of hyperlipidemia and atherosclerosis. Clin Chem (1999) 0.81
The effect of moderate alcohol consumption as either red or white wine in the C57BL/6 mouse atherosclerosis model. Coron Artery Dis (1999) 0.81
Red wine does not reduce mature atherosclerosis in apolipoprotein E-deficient mice. Circulation (2001) 0.79
Alcohol feeding impedes early atherosclerosis in low-density lipoprotein receptor knockout mice: factors in addition to high-density lipoprotein-apolipoprotein A1 are involved. Alcohol Clin Exp Res (1997) 0.79
Acute psychological stress accelerates reverse cholesterol transport via corticosterone-dependent inhibition of intestinal cholesterol absorption. Circ Res (2012) 1.43
New insights into the molecular actions of plant sterols and stanols in cholesterol metabolism. Atherosclerosis (2008) 1.29
Liver X receptor-mediated activation of reverse cholesterol transport from macrophages to feces in vivo requires ABCG5/G8. J Lipid Res (2008) 1.19
A genomewide exploration suggests a new candidate gene at chromosome 11q23 as the major determinant of plasma homocysteine levels: results from the GAIT project. Am J Hum Genet (2005) 1.15
The nuclear cofactor DOR regulates autophagy in mammalian and Drosophila cells. EMBO Rep (2009) 1.14
Identification of a novel modulator of thyroid hormone receptor-mediated action. PLoS One (2007) 1.08
Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential. Circ Res (2004) 1.00
Platelet-activating factor acetylhydrolase is mainly associated with electronegative low-density lipoprotein subfraction. Circulation (2003) 0.99
Apolipoprotein modulation of streptococcal serum opacity factor activity against human plasma high-density lipoproteins. Biochemistry (2009) 0.97
Density distribution of electronegative LDL in normolipemic and hyperlipemic subjects. J Lipid Res (2002) 0.96
The cholesterol content of Western diets plays a major role in the paradoxical increase in high-density lipoprotein cholesterol and upregulates the macrophage reverse cholesterol transport pathway. Arterioscler Thromb Vasc Biol (2011) 0.95
Latent autoimmune diabetes in adults is perched between type 1 and type 2: evidence from adults in one region of Spain. Diabetes Metab Res Rev (2013) 0.95
In vivo macrophage-specific RCT and antioxidant and antiinflammatory HDL activity measurements: New tools for predicting HDL atheroprotection. Atherosclerosis (2009) 0.95
Apolipoprotein A-II, genetic variation on chromosome 1q21-q24, and disease susceptibility. Curr Opin Lipidol (2004) 0.92
Cyclooxygenase 2 inhibition exacerbates palmitate-induced inflammation and insulin resistance in skeletal muscle cells. Endocrinology (2009) 0.90
Hypocholesterolemia, foam cell accumulation, but no atherosclerosis in mice lacking ABC-transporter A1 and scavenger receptor BI. Atherosclerosis (2011) 0.89
Identification of ZNF366 and PTPRD as novel determinants of plasma homocysteine in a family-based genome-wide association study. Blood (2009) 0.89
Impact of the LDL subfraction phenotype on Lp-PLA2 distribution, LDL modification and HDL composition in type 2 diabetes. Cardiovasc Diabetol (2013) 0.89
Changes in low-density lipoprotein electronegativity and oxidizability after aerobic exercise are related to the increase in associated non-esterified fatty acids. Atherosclerosis (2002) 0.88
Effect of improving glycemic control in patients with type 2 diabetes mellitus on low-density lipoprotein size, electronegative low-density lipoprotein and lipoprotein-associated phospholipase A2 distribution. Am J Cardiol (2012) 0.88
Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome. Arterioscler Thromb Vasc Biol (2009) 0.87
Direct evidence in vivo of impaired macrophage-specific reverse cholesterol transport in ATP-binding cassette transporter A1-deficient mice. Biochim Biophys Acta (2005) 0.87
Manipulation of inflammation modulates hyperlipidemia in apolipoprotein E-deficient mice: a possible role for interleukin-6. Cytokine (2006) 0.86
Identification of a novel mutation in the ANGPTL3 gene in two families diagnosed of familial hypobetalipoproteinemia without APOB mutation. Clin Chim Acta (2011) 0.86
[Adiponectin: a new link between obesity, insulin resistance and cardiovascular disease]. Med Clin (Barc) (2005) 0.86
Autophagy-regulating TP53INP2 mediates muscle wasting and is repressed in diabetes. J Clin Invest (2014) 0.86
Serum soluble transferrin receptor concentrations are increased in central obesity. Results from a screening programme for hereditary hemochromatosis in men with hyperferritinemia. Clin Chim Acta (2008) 0.85
Deficiency in monocyte chemoattractant protein-1 modifies lipid and glucose metabolism. Exp Mol Pathol (2007) 0.85
Turpentine-induced inflammation reduces the hepatic expression of the multiple drug resistance gene, the plasma cholesterol concentration and the development of atherosclerosis in apolipoprotein E deficient mice. Biochim Biophys Acta (2005) 0.85
Subcutaneous fat shows higher thyroid hormone receptor-alpha1 gene expression than omental fat. Obesity (Silver Spring) (2009) 0.85
Innovative continuous non-invasive cuffless blood pressure monitoring based on photoplethysmography technology. Intensive Care Med (2013) 0.85
Genome-wide linkage analysis for identifying quantitative trait loci involved in the regulation of lipoprotein a (Lpa) levels. Eur J Hum Genet (2008) 0.84
Overexpression of human apolipoprotein A-II in transgenic mice does not impair macrophage-specific reverse cholesterol transport in vivo. Arterioscler Thromb Vasc Biol (2005) 0.84
Stage-specific remodeling of atherosclerotic lesions upon cholesterol lowering in LDL receptor knockout mice. Am J Pathol (2011) 0.84
Sitosterolemia: diagnosis, investigation, and management. Curr Atheroscler Rep (2014) 0.83
Hepatic lipase- and endothelial lipase-deficiency in mice promotes macrophage-to-feces RCT and HDL antioxidant properties. Biochim Biophys Acta (2013) 0.83
Homocysteine and cognitive impairment. Relation with diagnosis and neuropsychological performance. Dement Geriatr Cogn Disord (2008) 0.83
Evaluation of two nonisotopic immunoassays for determination of glutamic acid decarboxylase and tyrosine phosphatase autoantibodies in serum. Clin Chem (2004) 0.82
Changes in intestinal and liver global gene expression in response to a phytosterol-enriched diet. Atherosclerosis (2005) 0.82
The role of the gut in reverse cholesterol transport--focus on the enterocyte. Prog Lipid Res (2013) 0.82
Dietary phytosterols modulate T-helper immune response but do not induce apparent anti-inflammatory effects in a mouse model of acute, aseptic inflammation. Life Sci (2007) 0.81
Differential effects of gemfibrozil and fenofibrate on reverse cholesterol transport from macrophages to feces in vivo. Biochim Biophys Acta (2010) 0.81
Folic acid supplementation delays atherosclerotic lesion development in apoE-deficient mice. Life Sci (2006) 0.81
Liver triglyceride content in HIV-1-infected patients on combination antiretroviral therapy studied with 1H-MR spectroscopy. Antivir Ther (2007) 0.81
Human scavenger protein AIM increases foam cell formation and CD36-mediated oxLDL uptake. J Leukoc Biol (2013) 0.81
Rat liver lipogenesis is modulated by interleukin-15. Int J Mol Med (2004) 0.80
Identification of novel type 2 diabetes candidate genes involved in the crosstalk between the mitochondrial and the insulin signaling systems. PLoS Genet (2012) 0.80
Differential intestinal mucosal protein expression in hypercholesterolemic mice fed a phytosterol-enriched diet. Proteomics (2007) 0.79
Increased plasma levels of plant sterols and atherosclerosis: a controversial issue. Curr Atheroscler Rep (2009) 0.79
Strength fitness and body weight status on markers of cardiometabolic health. Med Sci Sports Exerc (2015) 0.79
Macrophage ABCA5 deficiency influences cellular cholesterol efflux and increases susceptibility to atherosclerosis in female LDLr knockout mice. Biochem Biophys Res Commun (2010) 0.79
Seeking novel targets for improving in vivo macrophage-specific reverse cholesterol transport: translating basic science into new therapies for the prevention and treatment of atherosclerosis. Curr Vasc Pharmacol (2011) 0.79
CETP activity variation in mice does not affect two major HDL antiatherogenic properties: macrophage-specific reverse cholesterol transport and LDL antioxidant protection. Atherosclerosis (2007) 0.79
ATP-binding cassette G5/G8 deficiency causes hypertriglyceridemia by affecting multiple metabolic pathways. Biochim Biophys Acta (2011) 0.79
Structural and functional analysis of APOA5 mutations identified in patients with severe hypertriglyceridemia. J Lipid Res (2013) 0.78
Effects of deletion of macrophage ABCA7 on lipid metabolism and the development of atherosclerosis in the presence and absence of ABCA1. PLoS One (2012) 0.78
Phytosterols inhibit the tumor growth and lipoprotein oxidizability induced by a high-fat diet in mice with inherited breast cancer. J Nutr Biochem (2012) 0.78
Mast cell activation in vivo impairs the macrophage reverse cholesterol transport pathway in the mouse. Arterioscler Thromb Vasc Biol (2011) 0.78
Methionine-induced hyperhomocysteinemia impairs the antioxidant ability of high-density lipoproteins without reducing in vivo macrophage-specific reverse cholesterol transport. Mol Nutr Food Res (2013) 0.78
ApoA-I(MALLORCA) impairs LCAT activation and induces dominant familial hypoalphalipoproteinemia. J Lipid Res (2002) 0.78
Genetically based hypertension generated through interaction of mild hypoalphalipoproteinemia and mild hyperhomocysteinemia. J Hypertens (2007) 0.78
Resveratrol administration or SIRT1 overexpression does not increase LXR signaling and macrophage-to-feces reverse cholesterol transport in vivo. Transl Res (2012) 0.77
Paradoxical exacerbation of combined hyperlipidemia in human apolipoprotein A-II transgenic mice treated with fenofibrate. Biochim Biophys Acta (2005) 0.77
Antiatherogenic role of high-density lipoproteins: insights from genetically engineered-mice. Front Biosci (2006) 0.77
Patients with MEN-1 are more insulin-resistant than their non-affected relatives. Eur J Intern Med (2005) 0.77
Thromboplastin-thrombomodulin-mediated time and serum folate levels are genetically correlated with the risk of thromboembolic disease: results from the GAIT project. Thromb Haemost (2002) 0.77
Standardization of a method to evaluate the antioxidant capacity of high-density lipoproteins. Int J Biomed Sci (2009) 0.77
Apolipoprotein A5 S19W may play a role in dysbetalipoproteinemia in patients with the Apo E2/E2 genotype. Clin Chem (2006) 0.77
Are LXR-regulated genes a major molecular target of plant sterols/stanols? Atherosclerosis (2007) 0.77
Phenytoin treatment reduces atherosclerosis in mice through mechanisms independent of plasma HDL-cholesterol concentration. Atherosclerosis (2004) 0.77
Elimination of macrophages drives LXR-induced regression both in initial and advanced stages of atherosclerotic lesion development. Biochem Pharmacol (2013) 0.76
[Vitamin treatments that lower homocysteine concentration: can they decrease cerebrovascular disease in primary prevention?]. Rev Neurol (2010) 0.76
Phytosterol-mediated inhibition of intestinal cholesterol absorption is independent of ATP-binding cassette transporter A1. Br J Nutr (2006) 0.76
High-density lipoprotein cholesterol targeting for novel drug discovery: where have we gone wrong? Expert Opin Drug Discov (2013) 0.76
On the mechanisms by which human apolipoprotein A-II gene variability relates to hypertriglyceridemia. Circulation (2002) 0.76
HDL and lifestyle interventions. Handb Exp Pharmacol (2015) 0.75
[Basic mechanisms: structure, function and metabolism of plasma lipoproteins]. Clin Investig Arterioscler (2013) 0.75
Genetic analysis does not confirm non-classical congenital adrenal hyperplasia in more than a third of the women followed with this diagnosis. Hormones (Athens) (2014) 0.75
Mechanisms of HDL deficiency in mice overexpressing human apoA-II. J Lipid Res (2002) 0.75